| Literature DB >> 34767135 |
Carolyn DiGuiseppi1, Tessa Crume2, Julia Van Dyke2, Katherine R Sabourin2, Gnakub N Soke3, Lisa A Croen4, Julie L Daniels5, Li-Ching Lee6, Laura A Schieve3, Gayle C Windham7, Sandra Friedman8, Cordelia Robinson Rosenberg8.
Abstract
The association of autism spectrum disorder (ASD) with self-reported maternal cannabis use from 3 months pre-conception to delivery ("peri-pregnancy") was assessed in children aged 30-68 months, born 2003 to 2011. Children with ASD (N = 1428) were compared to children with other developmental delays/disorders (DD, N = 1198) and population controls (POP, N = 1628). Peri-pregnancy cannabis use was reported for 5.2% of ASD, 3.2% of DD and 4.4% of POP children. Adjusted odds of peri-pregnancy cannabis use did not differ significantly between ASD cases and DD or POP controls. Results were similar for any use during pregnancy. However, given potential risks suggested by underlying neurobiology and animal models, further studies in more recent cohorts, in which cannabis use and perception may have changed, are needed.Entities:
Keywords: Autism spectrum disorder; Cannabis; Epidemiology; Marijuana
Mesh：
Year: 2021 PMID： 34767135 PMCID： PMC9112286 DOI： 10.1007/s10803-021-05339-4
Source DB: PubMed Journal: J Autism Dev Disord ISSN： 0162-3257